Effects of R-102444, an orally active 5-HT2A receptor antagonist, in rat models of peripheral vascular disease-Reference-Cited by-同舟云学术

Effects of R-102444, an orally active 5-HT2A receptor antagonist, in rat models of peripheral vascular disease

Published:2004-02 Issue:1 Volume:41 Page:7-13
ISSN:1537-1891
Container-title:Vascular Pharmacology
language:en
Short-container-title:Vascular Pharmacology

Author:

Ogawa Taketoshi,Sugidachi Atsuhiro,Tanaka Naoki,Fujimoto Koichi,Asai Fumitoshi

Publisher

Elsevier BV

Subject

Pharmacology,Molecular Medicine,Physiology

Reference31 articles.

1. Protective effect of ticlopidine on experimentally induced peripheral arterial occlusive disease in rats;Ashida;Thromb. Res.,1980

2. Diabetes mellitus, vascular disease and thrombosis;Banga;Clin. Haematol.,1986

3. Intraplatelet serotonin in patients with diabetes mellitus and peripheral vascular disease;Barradas;Eur. J. Clin. Investig.,1988

4. LY215840, a potent 5-hydroxytryptamine (5-HT)2 receptor antagonist, blocks vascular and platelet 5-HT2 receptors and delays occlusion in a rabbit model of thrombosis;Cohen;J. Pharmacol. Exp. Ther.,1992

5. 5-hydroxytryptamine and platelet aggregation;De Clerck;Fed. Proc.,1983

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HEMORHEOLOGICAL PROPERTIES OF THE 5-HT2A-ANTAGONIST OF THE 2-METHOXYPHENYL-IMIDAZOBENZIMIDAZOLE DERIVATIVE OF THE RU-31 COMPOUND AND CYPROHEPTADINE, IN COMPARISON WITH PENTHOXYPHYLLINE;Pharmacy & Pharmacology;2021-03-02

2. Peripheral artery disease and antiplatelet treatment;Current Opinion in Pharmacology;2018-04

3. Prasugrel, a Platelet P2Y 12 Receptor Antagonist, Improves Abnormal Gait in a Novel Murine Model of Thrombotic Hindlimb Ischemia;Journal of the American Heart Association;2016-04-03

4. Effects of prasugrel, a novel P2Y12 inhibitor, in rat models of cerebral and peripheral artery occlusive diseases;European Journal of Pharmacology;2009-06

5. Synthesis and in vivo evaluation of [O-methyl-11C](2R,4R)-4-hydroxy-2-[2-[2-[2-(3-methoxy)phenyl]ethyl]phenoxy]ethyl-1-methylpyrrolidine as a 5-HT2A receptor PET ligand;Nuclear Medicine and Biology;2006-05